The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, ...
For the longest time, it was assumed that 5-6% of kids had attention-deficit hyperactivity disorder (ADHD), but the rates are ...
Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a ...
President-elect Donald Trump is expected to nominate Robert F. Kennedy Jr. to lead the Department of Health and Human ...
Analyst Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Zevra Therapeutics (ZVRA – Research Report) and increased the ...
A paper shows how partnering with the community can lead to more inclusive health care, especially for individuals with ...
About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...
12h
Jonathan Brostoff planned to attend a suicide prevention event. Now, a suicide prevention movement is dedicated to his memory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback